Skip to main content
OpenTrials
Completed

NCT Number: NCT05351710

A Randomized Controlled Trial of an Exposure-Based Treatment for Perfectionism

This study is examining the efficacy of a computerized, exposure-based, intervention for perfectionism.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Perfectionism

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Florida State University, Department of Psychology

Tallahassee, Florida, 32306, United States

About this study

The aim of this study is to further test the efficacy of a short-term, computerized exposure-based treatment for perfectionism (ETP) by comparing it to a stress management condition. ETP consists of three tasks in which participants will repeatedly make mistakes during eight sessions over a two-week period (one session every 2 days).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Score of at least 29 on the Frost Multidimensional Perfectionism Scale- Concern over Mistakes subscale

Exclusion criteria

  • Currently participating in psychotherapy
  • Any changes to psychotropic medications in the past four weeks

Treatment and study plan

Exposure-Based Treatment for Perfectionism

Behavioral

Three tasks focused on exposures are completed. Each treatment session is approximately twenty minutes.

Stress Management

Behavioral

Videos focused on education about healthy habits and relaxation. Each session is approximately twenty minutes.

Primary outcomes

  1. Frost Multidimensional Perfectionism Scale (FMPS)- Concern Over Mistakes Subscale

    Time frame: Baseline, post treatment (2 weeks), and follow-up (6 weeks)

    Self-report questionnaire examining levels of perfectionism. The concern over mistakes sub-scale includes 9 items with scores ranging from 9 to 45 (higher scores signify higher levels of perfectionism).

Secondary outcomes

  1. Center for Epidemiological Studies Depression Scale (CES-D)

    Time frame: Baseline, post treatment (2 weeks), and follow-up (6 weeks)

    Self-report measure used to assess depressive symptoms. Total scores range from 0 to 60 with higher scores indicating a higher level of depressive symptoms.

  2. Generalized Anxiety Disorder-7

    Time frame: Baseline, post treatment (2 weeks), and follow-up (6 weeks)

    Self-report measure used to assess generalized anxiety symptoms. Scores range from 0 to 21 with higher scores indicating higher levels of generalized anxiety.

  3. Social Phobia Inventory (SPIN)

    Time frame: Baseline, post treatment (2 weeks), and follow-up (6 weeks)

    Self-report scale that measures social anxiety symptoms. Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety symptoms.

  4. ED-15

    Time frame: Baseline, post treatment (2 weeks), and follow-up (6 weeks)

    Self-report scale that measures eating disorder symptoms. Scores range from 0 to 6, with higher mean scores indicating higher levels of eating disorder symptoms.

  5. Irrational Procrastination Scale

    Time frame: Baseline, post treatment (2 weeks), and follow-up (6 weeks)

    Self-report scale that measures levels of procrastination. Scores range from 9 to 45 with higher scores indicating higher levels of procrastination.

Sponsors and collaborators

Lead sponsor

Florida State University

Other

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2023
First posted
Apr 28, 2022
Registry last updated
Aug 7, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.